Pharmaceutical Company Announces Final Clinical Trial Results For Bipolar Treatment
stockregion.app
Encouraged by these results, NRx Pharmaceuticals plans to seek accelerated FDA approval for NRX-101 for patients with bipolar depression at risk of akathisia.
Pharmaceutical Company Announces Final Clinical Trial Results For Bipolar Treatment
Pharmaceutical Company Announces Final…
Pharmaceutical Company Announces Final Clinical Trial Results For Bipolar Treatment
Encouraged by these results, NRx Pharmaceuticals plans to seek accelerated FDA approval for NRX-101 for patients with bipolar depression at risk of akathisia.